Publications

Original Papers

27th Annual Symposium of the International Cannabinoid Research Society, Montreal, Canada

Opioid-Sparing Effect of Cannabinoids: A Systematic Review and Meta-Analysis

Endocannabinoids in arthritis: current views and perspective

The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study

Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?

Invest in CannPal

CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals. The company is listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

Learn More

Original Papers

SUBSCRIBE

Invest in CannPal

Sorry to interrupt

SUBSCRIBE